William White

William White

William White joined InvestorPlace.com in 2013. He writes about a wide range of stocks across all industries, especially so-called “meme stocks” or “Reddit stocks.” Recently, his area of expertise has expanded to include cryptocurrencies, such as Bitcoin, Dogecoin, Ripple, and a myriad of other altcoins. Traders looking for additional insight into the stock market can follow him on Twitter.

Recent Articles

Why Is Earlyworks (ELWS) Stock Up 340% Today?

Earlyworks stock is rising higher on Wednesday after providing investors in ELWS with an update on stakes held by two people.

Why Is Brera (BREA) Stock Up 234% Today?

Brera stock is rising higher on Wednesday after the football manager club company announced updates BREA shareholders need to know about.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news affecting shares on Wednesday morning!

PLTR Stock: Palantir Announces Sponsorship of Inaugural AI Expo

Palantir Technologies stock is in the news Tuesday as PLTR investors react to it sponsoring the AI Expo for National Competitiveness.

Why Is BioNexus (BGLC) Stock Up 323% Today?

BioNexus stock is heading higher on Tuesday as shares of BGLC see heavy trading this morning without any clear news from the company.

Why Are Stocks Down Today?

Stocks are down today and investors wondering why are in the right place as we have the answer to that question for Tuesday!

Evercore ISI Is Warming Up to NextEra Energy (NEE) Stock

NextEra Energy stock is on the move Tuesday after Evercore ISI initiated coverage of NEE shares with a bull rating and price target.

UBS Just Upped Its Nvidia (NVDA) Stock Price Target

Nvidia stock is a hot topic among NVDA traders on Tuesday after the company's shares got a new $850 price target from UBS analysts.

Why Is Polished.com (POL) Stock Down 33% Today?

Polished.com stock is sliding lower on Tuesday as investors in POL react to the company missing a debt payment and other dangers.

Why Is G1 Therapeutics (GTHX) Stock Down 45% Today?

G1 Therapeutics stock is down on Tuesday after the company provided GTHX investors with an update on a Phase 3 clinical trial.